Office of the Director, National Institutes of Health; Notice of Meeting, 50435 [2017-23641]

Download as PDF Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration National Institutes of Health National Advisory Committee on Rural Health and Human Services Office of the Director, National Institutes of Health; Notice of Meeting asabaliauskas on DSKBBXCHB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as AGENCY: Health Resources and Service amended, notice is hereby given of a Administration (HRSA), Department of meeting of the Office of AIDS Research Health and Human Services (HHS). Advisory Council. The meeting will be open to the ACTION: Notice of charter renewal. public as indicated below, with attendance limited to space available. SUMMARY: HHS is hereby giving notice Individuals who plan to attend and that the charter for the National need special assistance, such as sign Advisory Committee on Rural Health language interpretation or other and Human Services (NACRHHS) has reasonable accommodations, should been renewed. The effective date of the notify the Contact Person listed below renewed charter is October 31, 2017. in advance of the meeting. The meeting will be closed to the FOR FURTHER INFORMATION CONTACT: Paul public in accordance with the Moore, Designate Federal Official, provisions set forth in section NACRHHS, HRSA, 5600 Fishers Lane, 552b(c)(9)(B), Title 5 U.S.C., as Room 17W41C, Rockville, Maryland amended, for the review of 20857, telephone (301) 443–0835, fax recommendations for the HHS (301) 443–2803 or by email at pmoore2@ Treatment and Prevention Guidelines hrsa.gov. for medical care of people living with HIV in the United States. SUPPLEMENTARY INFORMATION: Recommendations made from the NACRHHS provides advice to the working group to the OARAC will Secretary concerning the provision and include drug names, treatment financing of health care and human regimens, and prevention modalities to services in rural areas. The current be used for the clinical care of PLWHA. Committee was established under The Council may revise the draft Section 222 of the Public Health Service guidelines and change the content or Act, as amended, 42 U.S.C. 217a. In scope of treatment and prevention for accordance with Public Law 92–463, it HIV/AIDS as recommended in the final was chartered on October 30, 1987, has guidelines. Premature disclosure of draft been renewed at appropriate intervals, guidelines in an open meeting could and will operate until October 31, 2019. negatively impact health and safety due The Committee will continue to operate to the premature disclosure of in accordance with the provisions of the information to medical providers and Federal Advisory Committee Act the public. Draft guidelines could be (FACA). misunderstood and confuse medical providers and the public as to what is A copy of the NACRHHS charter is the current HHS guidelines for the available on the NACRHHS Web site at treatment and prevention of HIV/AIDS, https://www.hrsa.gov/ could lead to premature changes in advisorycommittees/rural/. A copy of treatment regimens and prevention the charter is also available on the modalities that affect the health and FACA database that is maintained by safety of PLWHA and the public. the Committee Management Secretariat Name of Committee: Office of AIDS under the General Services Research Advisory Council. Administration. The Web site for the Date: November 16, 2017. FACA database is https:// Open: 8:30 a.m. to 12:00 p.m. www.facadatabase.gov/. Agenda: OAR Director’s Report, updates Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017–23562 Filed 10–30–17; 8:45 am] BILLING CODE 4165–15–P VerDate Sep<11>2014 17:37 Oct 30, 2017 Jkt 244001 from the DHHS HIV Treatment and Prevention Guidelines, OAR Task Force on Cost Sharing, and plans for the Clinical Trials Networks from the National Institute of Allergy and Infectious Diseases. Place: National Institutes of Health, Room ID13, 5601 Fishers Lane, Bethesda, MD 20892. Closed: 12:30 p.m. to 1:00 p.m. Agenda: To evaluate and review recommendations for the HHS Treatment and Prevention Guidelines. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 50435 Place: National Institutes of Health, Room ID13, 5601 Fishers Lane, Bethesda, MD 20892. Open: 1:00 p.m. to 4:30 p.m. Agenda: Update from the National Heart, Lung, and Blood Institute on the merger of the MACS and WIHS, and updates on HIV/ AIDS Research Activities from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute on Aging. Place: National Institutes of Health Room ID13, 5601 Fishers Lane, Bethesda, MD 20892. Contact Person: Elizabeth S. Church, Ph.D., Executive Secretary , Office of AIDS Research, DPCPSI, Office of the Director, 5601 Fishers Lane, Room 2E–60, Rockville, MD 20852–9830, 240–627–3201, elizabeth.church@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.oar.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: October 26, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–23641 Filed 10–30–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, E:\FR\FM\31OCN1.SGM 31OCN1

Agencies

[Federal Register Volume 82, Number 209 (Tuesday, October 31, 2017)]
[Notices]
[Page 50435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23641]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Office of AIDS 
Research Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended, for the review of recommendations for the HHS Treatment and 
Prevention Guidelines for medical care of people living with HIV in the 
United States. Recommendations made from the working group to the OARAC 
will include drug names, treatment regimens, and prevention modalities 
to be used for the clinical care of PLWHA. The Council may revise the 
draft guidelines and change the content or scope of treatment and 
prevention for HIV/AIDS as recommended in the final guidelines. 
Premature disclosure of draft guidelines in an open meeting could 
negatively impact health and safety due to the premature disclosure of 
information to medical providers and the public. Draft guidelines could 
be misunderstood and confuse medical providers and the public as to 
what is the current HHS guidelines for the treatment and prevention of 
HIV/AIDS, could lead to premature changes in treatment regimens and 
prevention modalities that affect the health and safety of PLWHA and 
the public.

    Name of Committee: Office of AIDS Research Advisory Council.
    Date: November 16, 2017.
    Open: 8:30 a.m. to 12:00 p.m.
    Agenda: OAR Director's Report, updates from the DHHS HIV 
Treatment and Prevention Guidelines, OAR Task Force on Cost Sharing, 
and plans for the Clinical Trials Networks from the National 
Institute of Allergy and Infectious Diseases.
    Place: National Institutes of Health, Room ID13, 5601 Fishers 
Lane, Bethesda, MD 20892.
    Closed: 12:30 p.m. to 1:00 p.m.
    Agenda: To evaluate and review recommendations for the HHS 
Treatment and Prevention Guidelines.
    Place: National Institutes of Health, Room ID13, 5601 Fishers 
Lane, Bethesda, MD 20892.
    Open: 1:00 p.m. to 4:30 p.m.
    Agenda: Update from the National Heart, Lung, and Blood 
Institute on the merger of the MACS and WIHS, and updates on HIV/
AIDS Research Activities from the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development and the National 
Institute on Aging.
    Place: National Institutes of Health Room ID13, 5601 Fishers 
Lane, Bethesda, MD 20892.
    Contact Person: Elizabeth S. Church, Ph.D., Executive Secretary 
, Office of AIDS Research, DPCPSI, Office of the Director, 5601 
Fishers Lane, Room 2E-60, Rockville, MD 20852-9830, 240-627-3201, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.oar.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: October 26, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-23641 Filed 10-30-17; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.